NRAS mutation is the sole recurrent somatic mutation in large congenital melanocytic nevi

Journal of Investigative Dermatology

Volumn 134, Issue 4, 2014, Pages 1067-1074

  Charbel, Christelle ^a,b   Fontaine, Romain H ^a,b   Malouf, Gabriel G ^b,c   Picard, Arnaud ^b,d   Kadlub, Natacha ^b,d   El Murr, Nizar ^a,b   How Kit, Alexandre ^e   Su, Xiaoping ^f   Coulomb L'Hermine, Aurore ^b,g   Tost, Jorg ^e,h   Mourah, Samia ⁱ   Aractingi, Selim ^a,j,k   Guégan, Sarah ^a,b,l,m  

^a INSERM   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

^e FONDATION JEAN DAUSSET CEPH   (France)

^f UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^g ARMAND TROUSSEAU HOSPITAL   (France)

^h CENTRE NATIONAL DE GÉNOTYPAGE   (France)

ⁱ SAINT LOUIS HOSPITAL   (France)

^j UNIVERSITÉ PARIS DESCARTES   (France)

^k NONE   (France)

^l HÔPITAL TENON   (France)

^m CENTRE DE RECHERCHE SAINT ANTOINE   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA;

ALLELE; ARTICLE; BRAF GENE; CELL PROLIFERATION; CHILD; CLINICAL ARTICLE; CODON; CONGENITAL MELANOCYTIC NEVI; CONTROLLED STUDY; EXOME; FEMALE; GENE; GENE MUTATION; GENE SEQUENCE; GENETIC TRAIT; HIGH RESOLUTION MELTING ANALYSIS; HUMAN; HUMAN TISSUE; INFANT; MALE; MELANOCYTIC NEVUS; NRAS GENE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PYROSEQUENCING; SEX RATIO; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC MUTATION;

CELL PROLIFERATION; CHILD; CHILD, PRESCHOOL; DNA MUTATIONAL ANALYSIS; EXOME; FEMALE; GENES, RAS; GENOTYPE; GTP PHOSPHOHYDROLASES; HUMANS; INFANT; MALE; MELANOCYTES; MEMBRANE PROTEINS; MUTATION; NEVUS, PIGMENTED; PHENOTYPE; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTO-ONCOGENE PROTEINS B-RAF; RISK;

EID: 84896672554     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2013.429     Document Type: Article

References (36)

1. Ascierto PA, Schadendorf D, Berking C et al. (2013) MEK162 for patients with advanced melanoma harbouring NRAS or Val600 BRAF mutations: a non-randomised, open-label phase 2 study. Lancet Oncol 14:249-56
2. Bastian BC (2003) Understanding the progression of melanocytic neoplasia using genomic analysis: from fields to cancer. Oncogene 22:3081-6
3. Bastian BC, Wesselmann U, Pinkel D et al. (1999) Molecular cytogenetic analysis of Spitz nevi shows clear differences to melanoma. J Invest Dermatol 113:1065-9
4. Bauer J, Curtin JA, Pinkel D et al. (2007) Congenital melanocytic nevi frequently harbor NRAS mutations but no BRAF mutations. J Invest Dermatol 127:179-82
5. Berger MF, Lawrence MS, Demichelis F et al. (2011) The genomic complexity of primary human prostate cancer. Nature 470:214-20
6. Bett BJ (2006) Large or multiple congenital melanocytic nevi: occurrence of neurocutaneous melanocytosis in 1008 persons. J Am Acad Dermatol 54:767-77
7. Carr J, Mackie RM (1994) Point mutations in the N-ras oncogene in malignant melanoma and congenital naevi. Br J Dermatol 131:72-7
8. Chapman MA, Lawrence MS, Keats JJ et al. (2011) Initial genome sequencing and analysis of multiple myeloma. Nature 471:467-72
9. De Wijn RS, Zaal LH, Hennekam RC et al. (2010) Familial clustering of giant congenital melanocytic nevi. J Plast Reconstr Aesthet Surg 63: 906-13
10. DeDavid M, Orlow SJ, Provost N et al. (1996) Neurocutaneous melanosis: clinical features of large congenital melanocytic nevi in patients with manifest central nervous system melanosis. J Am Acad Dermatol 35: 529-38
11. Dessars B, De Raeve LE, Morandini R et al. (2009) Genotypic and gene expression studies in congenital melanocytic nevi: insight into initial steps of melanotumorigenesis. J Invest Dermatol 129:139-47
12. Devitt B, Liu W, Salemi R et al. (2011) Clinical outcome and pathological features associated, with NRAS mutation in cutaneous melanoma. Pigment Cell Melanoma Res 24:666-72
13. Frieden IJ, Williams ML (1994) Familial site-specific congenital melanocytic nevus: report of two families. Arch Dermatol 130:1075-6
14. Hale EK, Stein J, Ben-Porat L et al. (2005) Association of melanoma and neurocutaneous melanocytosis with large congenital melano-cytic naevi-results from the NYU-LCMN registry. Br J Dermatol 152: 512-7
15. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646-74
16. How Kit A, Mazaleyrat N, Daunay A et al. (2013) Sensitive detection of KRAS mutations using E-ice-COLD-PCR mutation enrichment and direct sequence identification. Hum Mutat 34:1568-80
17. Ichii-Nakato N, Takata M, Takayanagi S et al. (2006) High frequency of BRAFV600E mutation in acquired nevi and small congenital nevi, but low frequency of mutation in medium-sized congenital nevi. J Invest Dermatol 126:2111-8
18. Kinsler VA, Thomas AC, Ishida M et al. (2013) Multiple congenital melanocytic nevi and neurocutaneous melanosis are caused by postzygotic mutations in codon 61 of NRAS. J Invest Dermatol 133: 2229-36
19. Kinsler VA, Abu-Amero S, Budd P et al. (2012) Germline melanocortin-1-receptor genotype, is associated with severity of cutaneous phenotype in congenital melanocytic nevi: a role for, MC1R in human fetal development. J Invest Dermatol 132:2026-32
20. Krengel S, Hauschild A, Schafer T (2006) Melanoma risk in congenital melanocytic naevi: a systematic review. Br J Dermatol 155:1-8
21. Lee RS, Stewart C, Carter SL et al. (2012) A remarkably simple genome underlies highly malignant pediatric rhabdoid cancers. J Clin Invest 122:2983-8
22. Marghoob AA, Schoenbach SP, Kopf AW et al. (1996) Large congenital melanocytic nevi and the risk for the development of malignant melanoma. A prospective study. Arch Dermatol 132:170-5
23. Marth GT, Korf I, Yandell MD et al. (1999) A general approach to single-nucleotide polymorphism discovery. Nat Genet 23:452-6
24. Papp T, Pemsel H, Zimmermann R et al. (1999) Mutational analysis of the N-ras, p53, p16INK4a, CDK4, and MC1R genes in human congenital melanocytic naevi. J Med Genet 36:610-4
25. Papp T, Schipper H, Kumar K et al. (2005) Mutational analysis of the BRAF gene in human congenital and dysplastic melanocytic naevi. Melanoma Res 15:401-7
26. Pollock PM, Harper UL, Hansen KS et al. (2003) High frequency of BRAF mutations in nevi. Nat Genet 33:19-20
27. Poynter JN, Elder JT, Fullen DR et al. (2006) BRAF and NRAS mutations in melanoma and melanocytic nevi. Melanoma Res 16:267-73
28. Qi RQ, He L, Zheng S et al. (2011) BRAF exon 15 T1799A mutation is common in melanocytic nevi, but less prevalent in cutaneous malignant melanoma, in Chinese Han. J Invest Dermatol 131:1129-38
29. Ross AL, Sanchez MI, Grichnik JM (2011) Molecular neurogenesis. Dermatol Res Pract 2011:463184
30. Ruiz-Maldonado R (2004) Measuring congenital melanocytic nevi. Pediatr. Dermatol. 21:178-9
31. Shyr D, Liu Q (2013) Next generation sequencing in cancer research and clinical application. Biol Proced Online 15:4
32. Stransky N, Egloff AM, Tward AD et al. (2011) The mutational landscape of head and neck squamous cell carcinoma. Science 333:1157-60
33. Takata M, Saida T (2006) Genetic alterations in melanocytic tumors. J Dermatol Sci 43:1-10
34. Tost J, Gut IG (2007) DNA methylation analysis by pyrosequencing. Nat Protoc 2:2265-75
35. Wu D, Wang M, Wang X et al. (2011) Lack of BRAF(V600E) mutations in giant congenital melanocytic nevi in a Chinese population. Am J Dermato-pathol 33:341-4
36. Wu J, Rosenbaum E, Begum S et al. (2007) Distribution of BRAF T1799A(V600E) mutations across various types of benign nevi: implications for melanocytic tumorigenesis. Am J Dermatopathol 29:534-7